Impax Receives FDA Approval for Generic Version of DIABETA® (Glyburide) Tablets, USP, 1.25 mg, 2.5 mg, and 5 mg
October 05, 2015 at 07:00 AM EDT
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has approved its generic ...
